Source: Investing.com ↗

H.C. Wainwright reiterates Ascendis Pharma stock rating at buy

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,166.47

+1.01%

ETH/USDT

$2,743.46

+0.69%

ZEC/USDT

$1,626.83

+7.39%

XRP/USDT

$1.62

+6.58%